» Articles » PMID: 28583198

A Brief Review: Adipose-derived Stem Cells and Their Therapeutic Potential in Cardiovascular Diseases

Overview
Publisher Biomed Central
Date 2017 Jun 7
PMID 28583198
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Adipose-derived stem cells (ADSCs) are easily obtained and expanded, and have emerged as a novel source of adult stem cells for the treatment of cardiovascular diseases. These cells have been shown to have the capability of differentiating into cardiomyocytes, vascular smooth muscle cells, and endothelial cells. Furthermore, ADSCs secrete a series of paracrine factors to promote neovascularization, reduce apoptosis, and inhibit fibrosis, which contributes to cardiac regeneration. As a novel therapy in the regenerative field, ADSCs still face various limitations, such as low survival and engraftment. Thus, engineering and pharmacological studies have been conducted to solve these problems. Investigations have moved into phase I and II clinical trials examining the safety and efficacy of ADSCs in the setting of myocardial infarction. In this review, we discuss the differentiation and paracrine functions of ADSCs, the strategies promoting their therapeutic efficacy, and their clinical usage.

Citing Articles

Emerging therapeutic benefit of platelet-rich fibrin as novel platelet concentrates in tissue engineering.

Suryawan I, Andrianto , Agita A, Ratri A, Nugraha R Glob Cardiol Sci Pract. 2025; 2024(5):e202446.

PMID: 39931451 PMC: 11807427. DOI: 10.21542/gcsp.2024.46.


Bioengineering strategies for regeneration of skin integrity: A literature review.

Shiraishi M, Sowa Y, Sunaga A, Yamamoto K, Okazaki M Regen Ther. 2025; 28():153-160.

PMID: 39790492 PMC: 11713503. DOI: 10.1016/j.reth.2024.12.006.


Stem cells and bio scaffolds for the treatment of cardiovascular diseases: new insights.

Razavi Z, Farokhi S, Mahmoudvand G, Karimi-Rouzbahani A, Farasati-Far B, Tahmasebi-Ghorabi S Front Cell Dev Biol. 2024; 12:1472103.

PMID: 39726717 PMC: 11669526. DOI: 10.3389/fcell.2024.1472103.


Safety and Efficacy of Adipose-Derived Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: A Systematic Review.

Giugni F, Giugni M, Pinesi H, Habrum F, Laranjeira L, Sady E Arq Bras Cardiol. 2024; 121(9):e20230830.

PMID: 39292063 PMC: 11495568. DOI: 10.36660/abc.20230830.


and -enriched adsc-exosomes mitigate PM exposure-exacerbated cardiac ischemia-reperfusion injury through the modulation of the BNIP3-MAP1LC3B-BBC3/PUMA pathway.

Lee T, Shen W, Chen Y, Lai T, Lin S, Lin S Autophagy. 2024; 21(2):374-393.

PMID: 39245438 PMC: 11760231. DOI: 10.1080/15548627.2024.2395799.


References
1.
Slevin M, Kumar P, Gaffney J, Kumar S, Krupinski J . Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin Sci (Lond). 2006; 111(3):171-83. DOI: 10.1042/CS20060049. View

2.
Yang M, Zhang G, Wang T, Wang X, Tang Y, Huang H . TBX18 gene induces adipose-derived stem cells to differentiate into pacemaker-like cells in the myocardial microenvironment. Int J Mol Med. 2016; 38(5):1403-1410. PMC: 5065308. DOI: 10.3892/ijmm.2016.2736. View

3.
Follin B, Juhl M, Cohen S, Pedersen A, Gad M, Kastrup J . Human adipose-derived stromal cells in a clinically applicable injectable alginate hydrogel: Phenotypic and immunomodulatory evaluation. Cytotherapy. 2015; 17(8):1104-18. DOI: 10.1016/j.jcyt.2015.04.008. View

4.
Song K, Wang Z, Li W, Zhang C, Lim M, Liu T . In vitro culture, determination, and directed differentiation of adult adipose-derived stem cells towards cardiomyocyte-like cells induced by angiotensin II. Appl Biochem Biotechnol. 2013; 170(2):459-70. DOI: 10.1007/s12010-013-0210-6. View

5.
Jeon E, Moon H, Lee M, Song H, Kim Y, Bae Y . Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism. J Cell Sci. 2006; 119(Pt 23):4994-5005. DOI: 10.1242/jcs.03281. View